APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Rotavirus Vaccine Market Analysis and Forecast 2026-2032

Report ID 174000100220 December 2025199 pages

Choose your research edition.

Industry ResearchHuman Rotavirus Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rotavirus Vaccine Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Human Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rotavirus Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rotavirus Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Rotavirus Vaccine include Bharat Biotech, GlaxoSmithKline and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Rotavirus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Rotavirus Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Human Rotavirus Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Rotavirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Rotavirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Rotavirus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Human Rotavirus Vaccine Segment by Company

Bharat Biotech

GlaxoSmithKline

Merck

Human Rotavirus Vaccine Segment by Type

Rotarix

RotaTeq

Lanzhou lamb

Rotavin-M1

Rotavac

Others

Human Rotavirus Vaccine Segment by Application

Hospitals & Clinics

Academic And Research

Others

Human Rotavirus Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Rotavirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rotavirus Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rotarix Major Manufacturers Table 3. RotaTeq Major Manufacturers Table 4. Lanzhou lamb Major Manufacturers Table 5. Rotavin-M1 Major Manufacturers Table 6. Rotavac Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Human Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospitals & Clinics Major Manufacturers Table 10. Academic And Research Major Manufacturers Table 11. Others Major Manufacturers Table 12. Human Rotavirus Vaccine Industry Trends Table 13. Human Rotavirus Vaccine Industry Drivers Table 14. Human Rotavirus Vaccine Industry Opportunities and Challenges Table 15. Human Rotavirus Vaccine Industry Restraints Table 16. Global Human Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Human Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Human Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Human Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 20. Global Human Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 21. Global Human Rotavirus Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Human Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 23. Global Human Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 24. Global Human Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 25. Global Human Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 26. Global Human Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Human Rotavirus Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 30. Global Human Rotavirus Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Human Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Human Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Human Rotavirus Vaccine Manufacturers, Product Type & Application Table 34. Global Human Rotavirus Vaccine Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Human Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Human Rotavirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 41. Global Human Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 42. Global Human Rotavirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 44. Global Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 45. Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 46. Global Human Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 47. Global Human Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 48. Global Human Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 49. Global Human Rotavirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 53. Global Human Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 54. Global Human Rotavirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 56. Global Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 58. Global Human Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 59. Global Human Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 60. Global Human Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. Bharat Biotech Company Information Table 62. Bharat Biotech Business Overview Table 63. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Bharat Biotech Human Rotavirus Vaccine Product Portfolio Table 65. Bharat Biotech Recent Development Table 66. GlaxoSmithKline Company Information Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio Table 70. GlaxoSmithKline Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Human Rotavirus Vaccine Product Portfolio Table 75. Merck Recent Development Table 76. North America Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 79. North America Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 80. North America Human Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Human Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 85. North America Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 86. North America Human Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Human Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Human Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Human Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 92. North America Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 93. North America Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 94. North America Human Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Human Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 97. Canada Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 98. Europe Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 101. Europe Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 102. Europe Human Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Human Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 107. Europe Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 108. Europe Human Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Human Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Human Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Human Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. Europe Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 115. Europe Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 116. Europe Human Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Human Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 119. France Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 120. U.K. Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 121. Italy Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 123. China Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 124. China Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 125. China Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 126. China Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 127. China Human Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Human Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 130. China Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 131. China Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 132. China Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 133. China Human Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Human Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 138. Asia Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 139. Asia Human Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Human Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 144. Asia Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 145. Asia Human Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Human Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Human Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Human Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Asia Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 152. Asia Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 153. Asia Human Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Human Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 156. South Korea Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 157. India Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Australia Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Human Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Human Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 164. SAMEA Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 165. SAMEA Human Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Human Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Human Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Human Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 170. SAMEA Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 171. SAMEA Human Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Human Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Human Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Human Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. SAMEA Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 178. SAMEA Human Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 179. SAMEA Human Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Human Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Argentina Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Chile Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Colombia Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Peru Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Israel Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 188. UAE Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Turkey Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Iran Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Egypt Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Human Rotavirus Vaccine Distributors List Table 195. Human Rotavirus Vaccine Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Human Rotavirus Vaccine Image Figure 2. Global Human Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rotarix Image Figure 5. RotaTeq Image Figure 6. Lanzhou lamb Image Figure 7. Rotavin-M1 Image Figure 8. Rotavac Image Figure 9. Others Image Figure 10. Global Human Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Human Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospitals & Clinics Image Figure 13. Academic And Research Image Figure 14. Others Image Figure 15. Global Human Rotavirus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Human Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 17. Global Human Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Human Rotavirus Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Human Rotavirus Vaccine Revenue Market Share by Region (2021-2032) Figure 20. Global Human Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 21. Global Human Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Human Rotavirus Vaccine Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Human Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Europe Human Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. China Human Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Human Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Human Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 28. Global Human Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Human Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Human Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Human Rotavirus Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 34. Global Human Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Human Rotavirus Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 37. Global Human Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Human Rotavirus Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 40. Global Human Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Human Rotavirus Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 43. North America Human Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 44. North America Human Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 45. North America Human Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 46. North America Human Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 47. North America Human Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 48. North America Human Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 49. Europe Human Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 50. Europe Human Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 51. Europe Human Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 52. Europe Human Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 53. Europe Human Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 54. Europe Human Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 55. China Human Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 56. China Human Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 57. China Human Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 58. China Human Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Human Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 60. Asia Human Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 61. Asia Human Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 62. Asia Human Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 63. Asia Human Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 64. Asia Human Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 65. SAMEA Human Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 66. SAMEA Human Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 67. SAMEA Human Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 68. SAMEA Human Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 69. SAMEA Human Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 70. SAMEA Human Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 71. Human Rotavirus Vaccine Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Human Rotavirus Vaccine Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Rotarix
  • RotaTeq
  • Lanzhou lamb
  • Rotavin-M1
  • Rotavac
  • Others
Applications
  • Hospitals & Clinics
  • Academic And Research
  • Others
Companies covered
  • Bharat Biotech
  • GlaxoSmithKline
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Rotavirus Vaccine Market by Type
  3. 1.2.1 Global Human Rotavirus Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rotarix
  5. 1.2.3 RotaTeq
  6. 1.2.4 Lanzhou lamb
  7. 1.2.5 Rotavin-M1
  8. 1.2.6 Rotavac
  9. 1.2.7 Others
  10. 1.3 Human Rotavirus Vaccine Market by Application
  11. 1.3.1 Global Human Rotavirus Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospitals & Clinics
  13. 1.3.3 Academic And Research
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Human Rotavirus Vaccine Market Dynamics
  1. 2.1 Human Rotavirus Vaccine Industry Trends
  2. 2.2 Human Rotavirus Vaccine Industry Drivers
  3. 2.3 Human Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Rotavirus Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Rotavirus Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Rotavirus Vaccine Revenue by Region
  3. 3.2.1 Global Human Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Rotavirus Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Rotavirus Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Rotavirus Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Rotavirus Vaccine Sales by Region
  9. 3.4.1 Global Human Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Rotavirus Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Human Rotavirus Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Human Rotavirus Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Rotavirus Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Human Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Rotavirus Vaccine Sales by Manufacturers
  6. 4.2.1 Global Human Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Rotavirus Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Rotavirus Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Human Rotavirus Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Rotavirus Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Human Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
5 Human Rotavirus Vaccine Market by Type
  1. 5.1 Global Human Rotavirus Vaccine Revenue by Type
  2. 5.1.1 Global Human Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Rotavirus Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Rotavirus Vaccine Sales by Type
  6. 5.2.1 Global Human Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Rotavirus Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Rotavirus Vaccine Price by Type
6 Human Rotavirus Vaccine Market by Application
  1. 6.1 Global Human Rotavirus Vaccine Revenue by Application
  2. 6.1.1 Global Human Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Rotavirus Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Rotavirus Vaccine Sales by Application
  6. 6.2.1 Global Human Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Rotavirus Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Rotavirus Vaccine Price by Application
7 Company Profiles
  1. 7.1 Bharat Biotech
  2. 7.1.1 Bharat Biotech Company Information
  3. 7.1.2 Bharat Biotech Business Overview
  4. 7.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio
  6. 7.1.5 Bharat Biotech Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Human Rotavirus Vaccine Product Portfolio
  18. 7.3.5 Merck Recent Developments
8 North America
  1. 8.1 North America Human Rotavirus Vaccine Market Size by Type
  2. 8.1.1 North America Human Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Rotavirus Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Human Rotavirus Vaccine Price by Type (2021-2032)
  5. 8.2 North America Human Rotavirus Vaccine Market Size by Application
  6. 8.2.1 North America Human Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Human Rotavirus Vaccine Price by Application (2021-2032)
  9. 8.3 North America Human Rotavirus Vaccine Market Size by Country
  10. 8.3.1 North America Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Rotavirus Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Rotavirus Vaccine Market Size by Type
  2. 9.1.1 Europe Human Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Rotavirus Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Rotavirus Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Human Rotavirus Vaccine Market Size by Application
  6. 9.2.1 Europe Human Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Rotavirus Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Human Rotavirus Vaccine Market Size by Country
  10. 9.3.1 Europe Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Rotavirus Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Rotavirus Vaccine Market Size by Type
  2. 10.1.1 China Human Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Human Rotavirus Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Human Rotavirus Vaccine Price by Type (2021-2032)
  5. 10.2 China Human Rotavirus Vaccine Market Size by Application
  6. 10.2.1 China Human Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Human Rotavirus Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Rotavirus Vaccine Market Size by Type
  2. 11.1.1 Asia Human Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Rotavirus Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Rotavirus Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Human Rotavirus Vaccine Market Size by Application
  6. 11.2.1 Asia Human Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Rotavirus Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Human Rotavirus Vaccine Market Size by Country
  10. 11.3.1 Asia Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Rotavirus Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Rotavirus Vaccine Market Size by Type
  2. 12.1.1 SAMEA Human Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Rotavirus Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Rotavirus Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Human Rotavirus Vaccine Market Size by Application
  6. 12.2.1 SAMEA Human Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Rotavirus Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Rotavirus Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Human Rotavirus Vaccine Market Size by Country
  10. 12.3.1 SAMEA Human Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Rotavirus Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Rotavirus Vaccine Value Chain Analysis
  2. 13.1.1 Human Rotavirus Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Rotavirus Vaccine Production Mode & Process
  6. 13.2 Human Rotavirus Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Rotavirus Vaccine Distributors
  9. 13.2.3 Human Rotavirus Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst